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Mao-Qiang Man3, Debra Crumrine3, Diane Roseeuw1, Kenneth R. Feingold3, Theodora Mauro3 and
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Neutralization of the normally acidic stratum corneum (SC) has deleterious consequences for permeability
barrier homeostasis and SC integrity/cohesion attributable to serine proteases (SPs) activation leading
to deactivation/degradation of lipid-processing enzymes and corneodesmosomes (CD). As an elevated pH
compromises SC structure and function, we asked here whether SC hyperacidification would improve the
structure and function. We lowered the pH of mouse SC using two polyhydroxyl acids (PHA), lactobionic acid
(LBA), or gluconolactone (GL). Applications of the PHA reduced the pH at all levels of SC of hairless mouse, with
further selective acidification of SC membrane domains, as shown by fluorescence lifetime imaging.
Hyperacidification improved permeability barrier homeostasis, attributable to increased activities of two key
membrane-localized, ceramide-generating hydrolytic enzymes (b-glucocerebrosidase and acidic sphingomye-
linase), which correlated with accelerated extracellular maturation of SC lamellar membranes. Hyperacidifica-
tion generated ‘‘supernormal’’ SC integrity/cohesion, attributable to an SP-dependent decreased degradation of
desmoglein-1 (DSG1) and the induction of DSG3 expression in lower SC. As SC hyperacidification improves the
structure and function, even of normal epidermis, these studies lay the groundwork for an assessment of the
potential utility of SC acidification as a therapeutic strategy for inflammatory dermatoses, characterized by
abnormalities in barrier function, cohesion, and surface pH.
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INTRODUCTION
The stratum corneum (SC) of mammalian skin normally
shows markedly acidic pH (Schade and Marchionini, 1928;
Ohman and Vahlquist, 1994), and its origins and impor-
tance are now being clarified (Hachem et al., 2003).
This so-called ‘‘acid mantle’’ originates at least in part from
two endogenous mechanisms that are operative in the outer
epidermis, that is, from the secretory phospholipase A2
(sPLA2)-mediated, extracellular generation of free fatty acids
(FFA) from phospholipids (Fluhr et al., 2001), and from the
activity of a sodium–proton exchanger, type 1 (NHE1) (Behne
et al., 2002), which localizes to the membrane domains of
the outer granular layer (Behne et al., 2002; Hachem et al.,
2005a). Evidence is accumulating that a third outer epidermal
mechanism, that is, generation of trans-urocanic acid from
filaggrin proteolysis (Krien and Kermici, 2000), could also be
important, as SC pH is elevated in filaggrin-deficient patients
with ichthyosis vulgaris (Ohman and Vahlquist, 1998).
Initially linked to antimicrobial function (Korting et al.,
1987), the acidic pH of the SC also regulates at least two
other epidermal functions, that is, permeability barrier
homeostasis and SC integrity/cohesion (the converse of
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desquamation). For example, barrier recovery is delayed
when acutely perturbed skin sites are exposed to a neutral pH
buffer (Mauro et al., 1998), and either pharmacological
blockade or knockout of sPLA2 or the NHE1 transporter alters
permeability barrier homeostasis and SC integrity/cohesion
(Fluhr et al., 2001; Behne et al., 2002). Moreover, neutraliza-
tion of murine SC with topical, non-toxic ‘‘superbases’’ also
negatively affects both permeability barrier homeostasis and
SC integrity and cohesion (Hachem et al., 2003, 2005b).
Furthermore, the abnormalities in the permeability barrier
function and SC integrity, characteristic of neonatal skin, are
linked to developmental alterations in endogenous acidifica-
tion, attributable in turn to reduced sPLA2 activity (Fluhr
et al., 2004a, 2004b). The negative consequences of SC
neutralization have been further linked to the activation of
serine proteases (SPs), which display neutral-to-alkaline pH
optima (Brattsand et al., 2005). When the pH-induced
increase in SP activity is sustained, key lipid-processing
enzymes (b-glucocerebrosidase (b-GlcCer’ase) and acidic
sphingomyelinase (aSMase)) and corneodesmosome (CD)-
constituent proteins are degraded (Fluhr et al., 2004b;
Hachem et al., 2005b). Inhibition of lamellar body (LB)
secretion comprises yet another recently described negative
consequence of pH-induced SP activation, signaled by the
protease-activated receptor-2 (Hachem et al., 2006a). Finally,
SP activation within SC converts pro-IL-1b to active
metabolites, which could initiate inflammation if enzyme
activity is sustained (Nylander-Lundqvist and Egelrud, 1997).
As most inflammatory dermatoses show not only primary
cytokine activation but also prominent abnormalities in
epidermal function, including impaired permeability barrier
homeostasis, abnormal desquamation, often increased colo-
nization by pathogenic microbes, pH-driven changes in SP,
and lipid-processing enzyme activity, could occur that are
clinically relevant. Moreover, not only inflamed skin but also,
as noted above, both neonatal and aged skin show a neutral
SC pH (Thune et al., 1988; Giusti et al., 2001; Bernard et al.,
2003), with known deleterious consequences (Giusti et al.,
2001; Choi et al., 2007). Furthermore, the notorious irritation
of skin, produced by alkaline soaps, could reflect SP-
mediated activation of primary cytokines. Thus, reversal of
the pH abnormality in these inflammatory dermatoses might
not only improve the permeability barrier function but it also
could reduce excess scale, decrease pathogen colonization,
and restrict inflammation. To assess the potential utility
of hyperacidification as a therapeutic/preventive strategy,
we first assessed here its effects on function in normal
hairless mouse skin. Our results show first that SC hyper-
acidification further improves epidermal structure and
function, even in normal skin, and second, that the basis
for improved function is selective acidification of membrane
domains in the lower SC.
RESULTS
PHA decrease pH throughout SC and selectively within
membrane microdomains
To assess the effects of polyhydroxyl acid (PHA) applications
on the pH of murine SC, we applied either lactobionic acid
(LBA) or gluconolactone (GL) (10% in propylene glycol/
ethanol; PG/E: 70:30) once to hairless mice flanks, followed
by the measurement of surface pH with a flat surface
electrode. A single application of either LBA or GL
significantly lowered the surface pH of SC in comparison-
neutralized LBA (nLBA in PG/E), GL (nGL in PG/E), or vehicle
(PG/E) alone (Figure 1a and b), with gradual recovery toward
basal (pretreatment) pH values over the subsequent
24–36 hours after PHA applications (Figures 1b and 2b).
Neither the PHA- nor the acidic buffer-treated sites displayed
evidence of irritation, assessed grossly as visible inflamma-
tion, histologically as absence of both epidermal hyperplasia
and dermal inflammation, and biophysically as an absence of
changes in transepidermal water loss (TEWL) levels (data not
shown).
To ascertain the localization of the PHA-induced pH
changes within SC, we next assessed pH at different levels of
SC of hairless mouse. As shown both by sequential tape
stripping and by fluorescence lifetime imaging microscopy
(FLIM) (see below), the LBA-induced decrease in pH at
3 hours extended to all levels of murine SC (4–5 strippings,
remove all layers of stratum disjunction in normal hairless
mice) (Figure 1c).
The acidic pH of normal mouse SC is inhomogeneously
distributed—although pH is lower in the outer than in the
lower SC (Ohman and Vahlquist, 1994), membrane domains
remain acidic even in the lower SC, extending to the stratum
granulosum (SG)–SC interface (Behne et al., 2002; Hanson
et al., 2002). To ascertain which levels and subcellular sites
of SC are acidified by the PHA, we next used FLIM to assess
the microdomain distribution of pH 1–3 hours after twice-
daily applications of either LBA or nLBA to hairless mouse
skin. The pH-sensitive fluorophore, 2,7-bis-(2-carboxyethyl)-
5-(and -6)-carboxyfluorescein (BCECF), was applied topically
shortly before biopsy, followed by the ex vivo examination of
samples in the confocal/FLIM microscope. pH of membrane
(extracellular) domains and intracellular (cytosolic) domains
was comparable in nLBA-treated skin (Figures 1d and 2). In
contrast, LBA treatment decreased pH at all levels of murine
SC, with a further reduction in membrane microdomains in
the lower SC (by about 1 pH unit), extending downward to
the SG–SC interface (Figures 1d and 2). Yet the pH of the
underlying nucleated layers did not appear to change
(Figure 2). Together, these studies show that (1) topical PHA
applications hyperacidify both the cytosolic and membrane
compartments of all levels of SC; (2) hyperacidification is
restricted to SC; and (3) hyperacidification further reduces pH
in SC membrane domains.
Hyperacidification of acutely disrupted skin accelerates barrier
recovery attributable to enhanced lipid processing
To determine whether hyperacidification improves perme-
ability barrier function in murine epidermis, we next assessed
barrier recovery kinetics following acute abrogation by tape
stripping after applications of PHA (as above). Both LBA and
GL were applied immediately after tape stripping (TEWL
X10mgcm2 hour1) to opposing flanks of hairless mice,
and TEWL was assessed 3 hours later. Barrier recovery
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kinetics accelerated significantly in sites that were acidified
with either LBA or GL in comparison with neutralized PHA
(nPHA) or vehicle-treated sites (Figure 3). As recovery rates
were comparable in neutralized PHA and vehicle-treated
sites, the PHA molecule alone does not appear to influence
permeability barrier homeostasis.
To assess the structural basis for accelerated recovery, we
next compared the LB secretory system 3hours after either
PHA or neutralized PHA applications to hairless mice.
Electron micrographs showed no differences in either the
cytosolic density (no. of) or the extent of secretion of LB in
PHA-treated vs control sites (data not shown). Instead, the
rate of formation of mature lamellar membranes appeared to
be accelerated in LBA-treated sites; that is, large numbers
of mature bilayers appeared within the SG–SC interface of
PHA-treated skin sites (Figure 4a, right panel, arrows),
whereas control sites showed fewer mature membranes at
this level These ultrastructural observations suggest that PHA
treatment accelerates the transformation of secreted LB
contents into ‘‘mature’’ lamellar bilayers.
To assess the biochemical basis for the PHA-induced
acceleration of barrier recovery and membrane maturation,
we next assessed changes in the activities of the two key
lipid-processing enzymes that show acidic pH optima,
b-GlcCer’ase and aSMase. By in situ zymography, the
activities of both b-GlcCer’ase and aSMase increased in the
lower SC after hyperacidification with either of the PHA after
acute barrier disruption (Figure 4b; GL results not shown).
The acidification-induced increases in enzyme activity in
murine epidermis were abolished when frozen sections of
hyperacidified skin were buffered to a neutral pH (Figure 4b;
in situ neutralized). Together, these results show that
hyperacidification accelerates barrier recovery by stimulating
the maturation of extracellular lamellar membranes, which in
turn is attributable to the enhanced activities of key lipid-
processing enzymes with acidic pH optima.
Hyperacidification improves SC integrity and reduces
desquamation rates attributable to a decrease in bulk SP activity
and induction of DSG3 expression
To assess the potential beneficial effects of hyperacidification
for SC integrity/desquamation, we next assessed SC integrity
after the application of LBA and GL to normal hairless mouse
skin, as above. Both of the PHA significantly improved SC
integrity in normal murine SC, a change that became
particularly evident deep in the SC (Figure 5a; note significant
differences in TEWL after both third and fourth strippings).
SC cohesion (amount of protein per stripping) also improved
significantly in the lower SC of PHA-treated murine skin,
shown as less protein removed per stripping (Figure 5b).
These results show that hyperacidification improves SC
integrity and cohesion in normal murine skin.
We next assessed the basis for improved SC integrity in
PHA-treated hairless mouse skin. Although CD degradation
normally begins 1–2 layers above the SG–SC interface, CD
instead persisted to the mid-to-outer SC in LBA-treated sites
(Figure 6a and b). These differences were confirmed further
by quantitative electron microscopy in randomized, coded
micrographs that showed a significant increase in CD density
in the lower SC in hyperacidified SC (Figure 6b). We next
assessed whether the LBA-induced increase in CD density
was attributable to retention of intact, constituent CD
proteins, assessed as the desmoglein-1 (DSG1) content in
western blots of SC extract from LBA and vehicle-treated
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Figure 1. Polyhydroxyl acids (PHA) produce a sustained decrease in SC pH at all levels of the murine stratum corneum. Either lactobionic acid (LBA)
and gluconolactone (GL) 10% was applied on murine flanks. (a) The decrease in surface SC pH is significant at 3 hours after PHA application in
comparison with neutralized (n)-LBA and nGL. (b) Surface pH recovers between 16 and 35 hours post single application of LBA. (c) LBA-induced
acidification extends deep into the SC after application of LBA as shown by the surface pH measurement after sequential tape stripping. (d) Similarly,
FLIM measurements show that LBA treatment decreased pH within both the cytosolic (intracellular: IC) and membrane microdomains (extracellular: EC)
at all levels of murine SC (by about 0.5 pH unit). LBA further acidified membrane microdomains in the lower SC (by about 1 pH unit), extending
downward to the SG–SC interface. Results shown in as the mean±SEM (n¼4–6).
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murine SC. To differentially address the effect of acidification
of the different layers of the SC, we removed the SC by
applying four sequential D-squames on the same area of the
flanks to a total of four areas per animal. The first two
D-squames were considered as upper SC and were extracted
separately from the third and fourth D-squames, which were
regarded as lower SC. Thus, a comparison by western
immunoblotting was carried out between the lower and
upper SC from both hyperacidified and control-treated mice.
When compared with vehicle, western immunoblotting
indicated a decreased proteolysis of DSG1 in hyperacidified
upper SC (Figure 6c). Surprisingly, DSG1 protein was
significantly decreased in hyperacidified lower SC compared
with vehicle l (Figure 6c). However, DSG3, which is
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Figure 2. FLIM imaging. Fluorescence Lifetime Imaging (FLIM) of unperturbed stratum corneum treated with LBA vs normalized LBA (nLBA), used as
a control. A series of five optical sections is shown, starting at the skin surface (top) and extending to the SG (8 mm). Images are shown en face, and pH is
measured by assessing the lifetime of the pH-sensitive moderator BCECF. Intensity imagines (lower two rows) are compared with lifetime images
(upper two rows). Light blue represents more neutral values, whereas green and yellow represent more acidic values. Amorphous acidic collections are
seen on the surface of the LBA but not on the nLBA-treated skin, likely corresponding to topically applied LBA. Owing to LBA, extracellular acidity
is more visible in the LBA-treated SC, although acidification diminishes at the SG, likely representing decreased LBA diffusion at deeper SC/SG levels.
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Figure 3. Hyperacidification accelerates barrier recovery in murine skin.
TEWL was measured before and at 0, 3, 24, and 48 hours after acute barrier
disruption by repeated Cellophane tape stripping on hairless mouse flanks.
Similarly, single application of either LBA (a) or GL (b) 10% immediately after
tape stripping to hairless mouse flanks significantly accelerated barrier
recovery kinetics 3 hours after disruption in comparison with nLBA, air
exposed (AE), V, or nGL. Results shown in as the mean±SEM (n¼ 4–6).
www.jidonline.org 503
J-P Hachem et al.
SC Acidification Improves Lipid Processing
normally absent in the SC, was increased in the protein
fraction of the lower SC treated with LBA (Figure 6c). The
3-hour time period between tape stripping and sample
collection should suffice for newly synthesized DSG3, as
new corneocytes are formed within 20minutes after tape
stripping (Demerjian et al., 2008). Also, we have found that
either neutralizing or acidifying the SC increases or decreases
sodium hydroxide anti-porter (NHE-1) in vivo in a time frame
of 3 hours (Hachem et al., 2005a). These results show that the
hyperacidification of murine SC leads to persistence of CD,
by the decreased degradation of DSG1 in the upper levels of
the SC and the induction of DSG3 expression in the lower
parts of the SC, providing a structural basis for the improved
SC integrity/cohesion of hyperacidified normal skin.
Although SP activity is quite low in SC of normal hairless
mouse under basal conditions, SP activity became virtually
undetectable in hyperacidified murine SC (Figure 7a). These
changes reflect a pH-induced inhibition in enzyme activity
alone, because neutralization of previously acidified frozen
tissue sections restored, or even increased, enzyme activity
(Figure 7a; in situ neutralization). Moreover, a complemen-
tary method to assess SP activity, the soybean trypsin
inhibitor (STI) binding assay, also showed less binding of
the SP inhibitor to hyperacidified SC, which is also indicative
of lower SP activity in PHA-treated skin (Figure 7b). In
addition, western immunoblotting for both kallikrein (klk)
5 and 7, the two SPs most clearly linked to SC desquamation,
showed decreased immunostaining for the proteolytically
active forms at 28 and 31 kDa, respectively (Figure 7d),
suggesting that hyperacidification decreases not only SP
activity but also the levels of proteolytically active protein.
Finally, both pro-klk5 and pro-klk7 are restricted to lipid raft
(LR) domains in hyperacidified SC, whereas both active forms
of the two SPs became non-LR bound in control samples
(Figure 7d). Together, these results show that the hyperaci-
dification of SC reduces the activity, active protein content,
and localization of SP.
In addition to SP, the SC also contains both aspartate and
cysteine proteases that show acidic pH optima (e.g.,
cathepsins D, E and L2), which have a potential role in
desquamation (Behrendt and Green, 1958; Igarashi et al.,
2004) and permeability barrier homeostasis (Egberts et al.,
2004). To ascertain whether SC hyperacidification also
affects cathepsin activity, we next carried out an in situ
pepstatin A binding assay on murine skin sites, treated earlier
with LBA. Unlike the application of control after tape
stripping, the apparent levels of pepstatin A binding to SC
was similar in LBA and nLBA skin sites (Figure 7c), suggesting
β-GlcCer’ase aSMAse
Figure 4. Hyperacidification-induced acceleration in barrier recovery
is attributable to accelerated lamellar membrane maturation consequent
to b-GlcCer’ase and aSMase activities. (a) LBA application immediately
after tape stripping of normal murine skin, accelerated processing of
lamellar bilayers at the stratum corneum–stratum granulosum (SC–SG)
interface (shown by white arrowheads on LBA-treated sites in right panel)
in comparison with nLBA-treated (left panel) 3 hours after acute barrier
disruption. RuO4 post-fixation. Bar¼200 nm. (b) Accelerated maturation
of lamellar bilayers to an increased in situ activity of b-GlcCer’ase and
aSMase in outer SG/inner SC interface 3 hours after acute barrier disruption
in comparison with nLBA treatment. The increase in b-GlcCer’ase and
aSMase activities is pH-dependent and not consequent on an increase
in enzyme mass, as in situ neutralization downregulates activities of
both enzymes to the initial basal level.
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Figure 5. Pre-acidification improves SC integrity/cohesion. To assess the
effects of skin acidification on SC integrity/cohesion, LBA and GL were
applied to hairless mice flanks. Integrity (a) markedly improved in the lower
SC 3 hours after a single application of LBA and GL. Similarly, a 3-hour
exposure of normal skin to either LBA or GL significantly improved SC
cohesion (b), again at the lower levels of the SC. Results shown as the
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Figure 6. Corneodesmosome (CD) density is increased following acute SC acidification. (a) Quantitative EM analysis shows a significant increase in CD
density on LBA-treated skin sites compared with nLBA treatment. (b) The number of CD (arrows) is increased and the lower SC appears more compacted in
LBA-treated sites shown by the increased number of inter-corneocyte hooks (asterisks). Bar¼ 0.25mm. (c) Western immunoblotting for DSG1 is reduced in
the lower SC in LBA-treated mice compared with vehicle treatment, whereas upper SC DSG1 are relatively protected from degradations. Yet induction of DSG3
expression is observed in LBA-treated animals (V¼ vehicle: propylene glycol: ethanol).
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Figure 7. Exposure of normal skin to acid pH is followed by a decrease in basal serine protease (SP) activity and kallikrein (klk) 5 and 7 activation.
(a and b) In situ zymography for serine protease (SP) and soybean trypsin inhibitor (STI) binding assay 3 hours after PHA treatment shows a decrease
in SP activity on SC acidification sites: LBA- vs nLBA-treated sites. The decrease in SP activities is not due to a decrease in enzyme mass as in situ
neutralization overrides LBA effect by reactivating SP. Yet fluorescent pepstatin A binding assay (c) was carried out on sections from LBA, nLBA-treated
normal skin or nLBA-treated tape-stripped (TS) skin to assess cathepsin D activity. Unlike barrier abrogation (TSþ nLBA), SC acidification alone does
suffice to increase enzyme activity, suggesting a secondary trigger besides pH for cathepsin D activation. (d) Western immunoblotting for klk7 and 5
shows decreased immunostaining for the active forms for both proteases (23 and 31 kDa, respectively) in the non-lipid raft (LR) fraction. Note the
restriction of pro-klk5 and 7 to the LR domains. A similar pattern of pro-cathespin D (52 kDa) expression with a virtually absent active cathepsin D on
both LBA- and nLBA-treated sites was found. Unlike klk5 and 7, pro-cathespin D is restricted to non-LR domains.
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that SC acidification alone did not suffice to increase enzyme
activity, whereas barrier status (nLBA þ TS) increases
cathepsin D activity as suggested earlier by Egberts et al.
(2004). In addition, only pro-cathepsin D (52 kDa) was
observed within the non-LR domains on western immuno-
blotting from the epidermal extracts of both LBA- and nLBA-
treated SC (Figure 7d), further suggesting that cathepsin D
activation does not change with hyperacidification. Together,
these results show that the improved SC integrity/cohesion of
hyperacidified SC is due to CD retention, attributable to a
further reduction in SP activity within treated SC.
DISCUSSION
In normal mammals, acute perturbations of the permeability
barrier elicit metabolic responses in the underlying epidermis
that rapidly restore barrier homeostasis. These responses
include the rapid secretion of a preformed pool of LBs
(Menon et al., 1985, 1992) and the stimulation of lipid
synthesis (Menon et al., 1985; Grubauer et al., 1989). This
initial cascade leads to partial barrier restoration, with the
final stages of barrier repair resulting sequentially from (1) an
upregulation of epidermal ceramide synthesis (Holleran
et al., 1991); (2) increased production of lipid-processing
enzymes (Holleran et al., 1992), such as b-GlcCer’ase
(Holleran et al., 1994); and (3) increased epidermal DNA
synthesis (Proksch et al., 1991). Normalization of barrier
function is largely completed by 35 hours in mice (Menon
et al., 1985; Grubauer et al., 1989). Given the rapidity of the
amplified response to acute barrier disruption in normal
epidermis, it is remarkable that a further decrease in the pH of
normal SC significantly accelerates the timetable of barrier
recovery in both humans and mice. Also of interest is the
apparent lack of toxicity of PHA applications to mouse skin,
reflecting the localization of metabolic effects to the SC
alone, as shown by FLIM analysis.
The improved function of hyperacidified SC could be
attributed not only to a broad reduction in SC pH but also to a
still further reduction of pH within SC membrane domains.
The decline in pH (from 5.5–6 to levels of p5) further
optimizes the activities of two key lipid-processing enzymes,
b-GlcCer’ase and aSMase, which both display optimum
activities at EpH p5.0 (Vaccaro et al., 1985; Takagi et al.,
1999), and which further localize to membrane domains of
the SC (these studies; Vaccaro et al., 1985; Hachem et al.,
2003; Igarashi et al., 2004). The pH-induced boost in lipid-
processing enzymes, in turn, appears to accelerate the rate
of maturation of secreted LB contents into broad lamellar
membranes. Thus, improved lipid processing accounts, at
least in part, for the hyperacidification-induced improvement
in permeability barrier homeostasis. Hyperacidification could
also improve barrier function by a second mechanism, that is,
a pH-induced decline in SP activity (Hachem et al., 2006a),
that could accelerate LB secretion (Denda et al., 1997), in a
protease-activated receptor-2-dependent manner (Hachem
et al., 2006a), but this mechanism was not assessed in these
studies.
The decline in pH also improves SC integrity and cohesion
(decreasing desquamation rates), because of a further
reduction in the already low basal SP activity to levels that
became almost undetectable. The further decline in SP
activity is consistent with the neutral-to-alkaline pH optima
of SP in general and of klk5 and klk7 specifically (Brattsand
et al., 2005). Although the epidermis contains a broad
panoply of klks, these two SP, and the recently described klk8
(Kishibe et al., 2007), appear to be the dominant, desqua-
matory SP of the SC (Caubet et al., 2004; Brattsand et al.,
2005). As SP activity reverts to basal or supernormal levels
when previously acidified SC is neutralized, a pH-induced
decrease in enzyme protein levels likely does not account for
the hyperacidification-induced decline in SP activity, a
conclusion supported by western blot quantitation of these
proteins. These observed shifts in enzyme activity have
important structural consequences that explain the apparent
benefits of hyperacidification for desquamation. Similarly,
Fartasch et al. (1997) showed that 3 weeks of treatment with a
4% glycolic enhanced desmosomal breakdown only within
the stratum disjunctum, whereas desmosomes of the stratum
compactum were unaffected and appeared more compacted
(Fartasch et al., 1997). Moreover, Kim et al. (2001) applied
both glycolic and lactic acid at 5% for 14 days on hairless
mouse flanks and showed a reduction in SC thickness on the
sites of acid application (Kim et al., 2001).
In our studies, we used a single application of PHA on
either intact or tape-stripped SC to assess the integrity and
permeability barrier function of SC. We showed that the
reduction in SP activity correlated with increased CD density
in the deeper layers of hyperacidified SC, explaining the
improved SC integrity and cohesion at this level and the
compacted appearance of the SC at deeper levels. Yet
decreased SP activity alone cannot explain the improved
integrity and the increase in CD density. We also observed
that SC hyperacidification induces the expression of DSG3,
which is normally absent from the SC. Although our
zymographic data clearly show a decrease in SP activity,
both klk5 and 7 could still retain some activity, even at lower
pH levels (Caubet et al., 2004). The observed increase in LB
secretion reported by Kim et al. (2001) could either be related
to a reduction in SP activity and protease-activated receptor-2
signaling of LB secretion (Hachem et al., 2006a) or it could
reflect increased epidermal proliferation, a well-known
consequence of topical alpha-hydroxyl acid applications
(Ditre et al., 1996). The SC pH gradient allows the precise
regulation of klk5 activity by controlling the interaction of this
SP with the SP inhibitor, LEKTI, leading to the release of
active klk from LEKTI–klk complexes at an acidic pH and klk-
mediated corneodesmosomal cleavage in the superficial
layers of the SC (Deraison et al., 2007). We propose,
therefore, that SC acidification allows the dissociation of
LEKTI–klk complexes, inhibiting DSG1 degradation in lower
SC. Klk5 still possesses a proteolytic activity profile at pH 5.6
(Caubet et al., 2004), activating the klk cascade and allowing
degradation of CDs (Caubet et al., 2004; Emami and
Diamandis, 2008). Mutations of LEKTI in the Netherton
syndrome cause unrestricted activation of SP, resulting in
DSG1 breakdown, also accompanied by a compensatory
expression of DSG3 (Hachem et al., 2006b), as observed
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here. Thus, the improved integrity and cohesion of the SC
from PHA treatment can likely be attributed to both a
decrease in bulk SC protease activity leading to DSG1
persistence and the induction of DSG3 in the lower SC.
As cysteine and aspartate proteases, two protease families
with acidic pH optima (i.e., cathepsin D, E, L2), are also
present in the SC (Bernard et al., 2003; Igarashi et al., 2004),
it is possible that hyperacidification of SC could accelerate
desquamation, based on increased cathepsin activity. Yet
hyperacidification alone under these conditions did not
appear to increase cathepsin D activity. These findings are
at odds with other work, which has shown, for example, that
glycolic acid applications increase desquamation rates in
parallel with an increase in cathepsin D activity in the outer
SC (Horikoshi et al., 2005). Yet the amounts of glycolic acid
applied in the Horikoshi group’s study was as high as 50%,
and surface pH was drastically reduced (to E2); hence, it is
possible that accelerated desquamation reflected toxic
effects, unrelated consequences of bulk a-hydroacids, and/or
suboptimal pH levels. Increased cathepsin D activates
transglutaminase-1, stimulating the formation of the cornified
envelope (Egberts et al., 2004), suggesting an alternate,
important target for this aspartate protease in barrier function.
The cysteine protease, cathepsin L2, another enzyme with an
acidic pH optimum, is also expressed as a pro-enzyme in the
lower layers of the SC, followed by its activation by as-yet
unidentified mechanisms in the outer SC layers (Bernard
et al., 2003). Thus, acidification alone also might not suffice
to activate cathepsin L2. In summary, it is likely that the
effects of hyperacidification are largely restricted to changes
in the activities of the relevant lipid-processing and desqua-
matory SP within the SC, as the activities of desquamatory
enzymes with an acidic pH do not appear to increase with
hyperacidification.
Yet hyperacidification could, in theory, have adverse
effects for the barrier should it decrease the activity of
another, important lipid-processing enzyme(s), with a neutral-
to-alkaline pH optimum, that is, sPLA2. This apparent
paradox can be explained by the fact that hyperacidification
is a key consequence of FFA generation by sPLA2 activity,
thereby improving barrier function, SC integrity/cohesion,
and membrane structure (Fluhr et al., 2004b). Thus,
exogenous hyperacidification, as used here, likely bypasses
the potentially negative consequences of reduced FFA
generation that could result from the inhibition of sPLA2.
Pertinently, the acidification of ceramide–cholesterol–FFA
mixtures in vitro further enhances membrane interactions
(Bouwsta et al., 2000), which could represent yet another
barrier-improving mechanism of hyperacidification.
The topical application of hydroxyl acids in peels or
formulation has been widely used for multiple dermatologi-
cal conditions from photoaging (Van Scott et al., 1996) to the
treatment of congenital (Van Scott and Yu, 1974) or acquired
hyperkeratosis (Van Scott and Yu, 1989). Ditre et al. (1996)
applied 25% glycolic, lactic, or citric acid to the forearm for 6
months, which caused an approximate 25% increase in skin
thickness (Ditre et al., 1996). Although the studies were
carried out on the forearms, the authors concluded that alpha
hydroxyl acids application produced a significant reversal of
epidermal and dermal markers of photoaging (Ditre et al.,
1996). In our studies, we used lower levels of topically
applied PHA not only to decrease SC pH but also to maintain
its levels within physiological ranges. Rawlings et al. (1996)
showed that the topical application of either L- or D-lactic
acid (4% in aqueous vehicle) improves permeability barrier
function in humans together with increased levels of
ceramides in the SC (Rawlings et al., 1996). Accordingly,
we found that acidification of membrane domains within the
lower SC (i.e., FLIM data) increases both b-GlcCer’ase and
aSMase activity, which in turn will increase the lipid
processing and ceramide content in the SC. Yet both
Rawlings et al. (1996) and Berardesca et al. (1997) also
found that the positive effects of either alpha-hydroxyl acids
or PHA on epidermal barrier function are not equal for all
acids. This could be linked to the differences in the
bioavailability of these acids within SC membrane domains
or to the effect of salt formation derived from the neutraliza-
tion of the applied acids. As our main aim in this study is to
assess SC acidification alone, we used as control for our
studies the neutralized form of the PHA, thus limiting the
positive or negative effects of salt formation. In addition, the
bioavailability within the deep domains of the SC PHA was
verified using FLIM.
In summary, hyperacidification generates a ‘‘super-bar-
rier’’ largely, if not solely, through its impact on the activities
of the lipid-processing and desquamatory enzymes. More-
over, the reduction in pH produces neither inflammation nor
hyperplasia, nor changes in epidermal lipid synthesis, further
evidence that, under these conditions, PHA do not affect the
underlying nucleated cell layers.
MATERIALS AND METHODS
Materials
Male hairless mice (Skh1/Hr), 6- to 8-weeks old, were purchased
form Charles River Laboratories (IFFA Credo, Brussels, Belgium) and
fed Purina mouse diet and water ad libitum. Four to six mice were
used for each treatment in the different experiments (total of 12–16
per experiment). Experiment propylene glycol, ethanol, and hydro-
chloric acid were from Fisher Scientific (Fairlane, NJ), whereas
HEPES buffer, GL (pKa¼ 2.98), and LBA (pKa¼ 3.2), two PHA, both
of which are ‘‘generally accepted as safe’’ (i.e., GRAS) ingredients,
were obtained from Sigma Chemicals (Bornem, Belgium). EnzChek
Protease Assay Kit (green fluorescence), Amplex Red Sphingomye-
linase and resorufin a-D-glucopyranoside, and green fluorescent
protease inhibitors (STI and pepstatin A) were purchased from
Invitrogen (Merelbeke, Belgium). D-Squame-100 tapes of 22mm
were purchased from CuDerm (Dallas, TX). Bradford protein assay
kits (Bio-Rad Protein Assay Dye), as well as lyophilized bovine
plasma gamma globulin, were purchased from Bio-Rad (Nazareth-
Eke, Belgium). All procedures were performed, while mice were
anesthetized with chloral hydrate, under protocols approved by
the animal care committees of the VAMC (San Francisco; the
Universitair Ziekenhuis-Vrije Universiteit Brussels). Hilltop cham-
bers of 25mm were purchased from Hilltop Research (Miamiville,
OH). Antibodies against klk5 and cathepsin D were purchased from
Abcam (Cambridge, UK), whereas the anti-klk7 antibodies were a
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generous gift from Biovitrium (Go¨teborg, Sweden). Antibodies against
DSG1 and DSG3 were purchased from Santa Cruz Biotechnology
(Tebu-Bio nv, Boechout, Belgium) and Invitrogen (Zymed).
Acidification protocols
Normal hairless mice were treated twice daily with a single topical
application of either LBA or GL (10% (vol/vol), pH 2.8 and 3.2) in
PG/E (7:3 (vol/vol)) to 7–8 cm2 areas on the animals’ flanks. Controls
were treated similarly with NaOH-neutralized-LBA or -GL (nLBA,
nGL) in the PG/E vehicle or vehicle alone. Surface pH was measured
with a glass surface electrode, as described above. Skin surface pH
was evaluated immediately before and after applications, as well as
at 1, 2–3, 6–8, 12, and 20, or 24 hours after applications.
Assessment of pH distribution by FLIM
Freshly excised mouse skin samples were obtained at various points
after LBA or vehicle treatment, using the fluorescent pH indicator,
BCECF (Invitrogen). BCECF (1mg of BCECF dissolved in phosphate-
buffered saline, then diluted in 70% ethanol to 500 ml) was applied to
the treated area four times at 30-minute intervals for 2hours, before
20mm2 punch biopsies were obtained and analyzed by two-photon
FLIM. FLIM was used to measure and localize intracellular and extra-
cellular pH throughout the SC (Behne et al., 2002; Hanson et al.,
2002). A Millenia-pumped Tsunami titanium:sapphire laser system
(Spectra-Physics, Mountain View, CA) was used as the two-photon
excitation source, and a two-photon excitation of the sample (o1mW)
was achieved by coupling the 800-nm output of the laser through the
epifluorescence port of a Zeiss LSMmicroscope (Thornwood, NY). The
excitation beam was diverted to the sample by a dichroic filter, and the
fluorescence was collected using a Hamamatsu (H7422, Bridgewater,
NJ) photomultiplier. Scanning mirrors and a  63 infinity-corrected oil
objective (Zeiss F Fluar, 1.3 NA) were used to image areas of 86mm2.
Z-slices (2–2.5mm per slice) were obtained by adjusting the objective
focus using a motorized driver (ASI Multi-Scan 4, Lexington, KY).
Lifetime data were acquired using the single-photon counting method.
Data evaluation and visualization were carried out directly using
image analysis software ImageJ (http://rsbweb.nih.gov/ij/index.html).
Lower lifetime values represent a more acidic pH. Lifetime values
were calibrated to pH values using a calibration curve constructed
with pH buffers from pH 4 to 10.
Assessment of epidermal functions
Permeability barrier recovery. To assess the permeability barrier
function, TEWL was measured under basal conditions, that is, before
acute barrier disruption by repeated Cellophane tape stripping of the
flanks of hairless mice (425mg cm2 hour1) using a Tewameter
(Courage and Khazaka, Cologne, Germany). Acute disruption was
followed by immediate applications of LBA, nLBA, GL, or nGL, as
above. Barrier recovery kinetics was assessed 3 hours after PHA or
vehicle applications.
SC integrity. To assess changes in SC integrity (i.e., resistance to
repeated stripping) in murine skin, sequential D-Squame tape
strippings in hairless mice were carried out by a single observer on
the flanks of hairless mice 3 hours after the last previous application
of LBA, GL nLBA, or nGL. TEWL was evaluated after each tape
stripping, with the rate of change in TEWL again compromising SC
integrity.
SC cohesion. The amount of protein removed per D-Squame
strip defines SC cohesion, as described previously (Dreher et al.,
1998). This microassay system was linear in the range of
1–10 mgml1, using either human SC from the heel callus or bovine
plasma g-globulin as the protein source (calculated slope
Rf¼ 0.0297±0.0006; Spearman’s coefficient: 0.999; Po0.0001).
Protein content per stripping was then determined using the Bio-Rad
Protein Assay Kit, with lyophilized, bovine g-globulin as the standard
in all assays. Each tape was incubated in 1ml of 1 M NaOH for 1 hour
at 37 1C in an incubator shaker at 80 r.p.m., and neutralized
thereafter by the addition of 1ml of 1 M HCl to the scintillation
vials. Subsequently, 0.2ml of this solution was mixed in 0.6ml
distilled water and 0.2ml of the Bio-Rad protein dye for 5minutes in
borosilicate tubes. After incubations, the reagents were transferred to
polystyrene cuvettes, and absorption was measured using a Genesys
5 spectrophotometer (Spectronic, Rochester, NY) at 595 nm. An
empty D-Squame tape, as well as distilled water incubated with the
Bio-Rad dye, served as negative controls. The amount of calculated
protein was then normalized to the skin surface area (mg per cm2).
The amount of removed protein per D-Squame strip corresponded
with previous reports of protein removed from untreated skin of
hairless mice (i.e., range 2.5–4mg per strip) (Dreher et al., 1998).
Enzyme activities by in situ zymography
SP. Frozen sections (8mm) from treated hairless mice were rinsed
with a washing solution (1% Tween 20 in deionized water) and
incubated for 2 hours with 250 ml of BODIPY-Fl-casein in deionized
water (2 ml/ml) at 37 1C. Sections were rinsed with the 1% Tween 20
washing solution, coverslipped, and visualized under a confocal
microscope (Leica TCS SP, Heidelberg, Germany) at an excitation
wavelength of 485 nm and an emission wavelength of 530 nm
(Dreher et al., 1998).
b-GlcCer’ase. Frozen sections (8 mm) from treated hairless mice
were washed with the 1% Tween 20 washing solution and incubated
for 2 hours with 250 ml of 1mM resorufin a-D-glucopyranoside in
deionized water at 37 1C. Sections were rinsed with the washing
solution, coverslipped, and visualized under the confocal micro-
scope at an excitation wavelength of 588 nm and an emission
wavelength of 644 nm.
aSMase. Frozen sections (8mm) from treated hairless mice were
washed with the 1% Tween 20 washing solution and incubated for
2 hours with 250ml of 100mM Amplex Red reagent (containing
2Uml1 horseradish peroxidase, 0.2Uml1 choline oxidase,
8Uml1 of alkaline phosphatase) in deionized water at 37 1C.
Sections were then rinsed with the washing solution, coverslipped,
and visualized under the confocal microscope at an excitation
wavelength of 588 nm and an emission wavelength of 644 nm.
Protease inhibitor binding assay. Frozen sections (8 mm) from
treated hairless mice were washed with the 1% Tween 20 washing
solution and incubated for 2 hours with either fluorescent STI (an SPI
inhibitor, 1mgml1) or pepstatin A (cathepsin inhibitor, 1 mgml1)
for 2 and hours at 37 1C. Sections were rinsed with the 1% Tween 20
washing solution, mounted, and visualized under a confocal micro-
scope (Leica TCS SP) at an excitation wavelength of 485 nm and an
emission wavelength of 530 nm.
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Protein isolation from epidermis
Lipid rafts and non-lipid raft fractions. After skin excision and
removal of subcutaneous fat with scalpel blades, samples were
floated on 10mM dithiothreitol solution in phosphate-buffered saline
for 1.5 hours at 37 1C. Subcellular fractions were isolated using
ReadyPrep Protein Extraction Kit (Signal and Cytoplasm; Bio-Rad)
according to the manufacturer’s protocol.
SC extracts. SC was isolated using sequential D-squame tape
strippings (20 D-squames per individual; CuDerm). Tapes were then
incubated overnight at 4 1C in 1% Triton X-100 and a protease
inhibitor cocktail (Complete Mini, Roche, Brussels, Belgium) in
phosphate-buffered saline, and then sonicated for 5minutes at room
temperature to extract proteins from the tapes, followed by
measurement of the protein content (Bio-Rad Protein Assay Kit).
Western immunoblotting
After protein isolation (see above), the protein content of the whole,
basal, and suprabasal epidermal extracts was determined. Equal
amounts of protein from each experimental group were loaded onto
NuPAGE Novex 10% Bis-Tris Gel (Novex Gel; Invitrogen). After
electrophoresis in slab gels, proteins were transferred onto nitrocellu-
lose membranes using the iBlot Dry Blotting System (Invitrogen) and
immunoblotted to detect primary antibodies using the Western Breeze
Lightening Chemiluminescence Kit (Invitrogen). Western immunoblot-
ting for KLK5 was carried out using the WesternDot 625 Goat Anti-
Rabbit Western Blot Kit (Invitrogen) and image detection was carried
out using the Image Station 4000MM (Kodak, Raytest, Germany).
Electron microscopy
Biopsy samples were taken from all treatment groups (n¼ 3 animals
from each experimental group) and processed for electron micro-
scopy. Samples were minced to o0.5mm3, fixed in modified
Karnovsky’s fixative overnight, and post-fixed in either 0.2%
ruthenium tetroxide (RuO4) or 1% aqueous osmium tetroxide
(OsO4) containing 1.5% potassium ferrocyanide. After fixation, all
samples were dehydrated in graded ethanol solutions, and
embedded in an Epon-epoxy mixture. Ultrathin sections were
examined, with or without further contrasting with lead citrate, in
an electron microscope (Zeiss 10A; Carl Zeiss, Thornwood, NY)
operated at 60 kV.
To quantify CD density by electron microscopy, 10 sequential
digital images of the outer epidermis were taken at random from
each sample, at  31,500 magnification, for quantitation. The ratio
between the total lengths of all CD to the total length of cornified
envelopes at the SG/SC junction, as well as the membrane length
surrounding the first SC cell layer, was determined using a
planimeter.
Statistical analyses
Statistical analyses were carried out using Prism 2 (GraphPad
Software, San Diego, CA). Two groups were compared using
Student’s t-test. Non-parametric Mann–Whitney statistical analyses
were carried out to compare percent ratios between different groups
of treatments (Morris 2000).
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